Vanguard Personalized Indexing Management’s Inozyme Pharma INZY Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,047	Closed	-$88.2K	–	2022
2025 Q2	$88.2K	Buy	22,047 +4,840	+28%	+$12K	﹤0.01%	1761
2025 Q1	$15.7K	Buy	+17,207	New	+$23.9K	﹤0.01%	1798

Vanguard Personalized Indexing Management's INZY Position: Q3 2025 in Review

Vanguard Personalized Indexing Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 22,047 shares — an estimated $88.2K sold.

Vanguard Personalized Indexing Management first reported a position in INZY in Q1 2025 and held it in 2 quarters. The position peaked at $88.2K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

Vanguard Personalized Indexing Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 22,047 Inozyme Pharma shares in Q3 2025, an estimated $88.2K.
Vanguard Personalized Indexing Management first reported a position in Inozyme Pharma in Q1 2025 and held it in 2 quarters.
Vanguard Personalized Indexing Management's Inozyme Pharma position peaked at $88.2K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2025, filed 31 Oct 2025.